R
RGEN
Repligen
164.98
-0.78-0.47%After Hours: 161.80 -3.18 -1.93%19:46 12/05 EST
OPEN/PREV CLOSE166.21/165.76
TODAY RANGE163.87-167.20
VOL499.49K
MARKET CAP9.29B
52 WEEK RANGE102.97-182.52
AVG VOL (3M)937.46K
% TURNOVER0.89%
TURNOVER--
P/E (TTM)6,394.57
% RANGE1.96%
EPS(TTM)0.0258
P/E(FORWARD)194.09
P/B4.458
BVPS37.01
DIVIDEND--
P/S14.59
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP8.65B
SHARES OUTSTANDING56.29M
NEXT EARNINGS02/18-02/23
FREE FLOAT52.46M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Reuters·11/26 21:31
Repligen CEO Olivier Loeillot Reports Disposal of Common Shares
Simply Wall St·11/24 10:27
A Look at Repligen’s (RGEN) Valuation Following Recent Share Price Gains
Benzinga·11/21 18:00
P/E Ratio Insights for Repligen
TipRanks·11/20 02:06
Repligen’s COO Makes a Significant Stock Sale!
Dow Jones·11/19 23:21
Stocks to Watch: Nvidia, Kulicke & Soffa, Regeneron
TipRanks·11/15 02:11
Director’s Multi-Million Dollar Stock Sale Shakes Up Repligen!
Reuters·11/14 21:56
Q/C Technologies Delays Quarterly Financial Report Filing
Reuters·11/14 21:55
Q/C Technologies Inc. Held Special Shareholder Meeting
Reuters·11/14 21:35
Repligen Director Anthony Hunt Reports Sale of Common Shares
Seeking Alpha·11/14 08:28
Repligen: Rare Growth In The Biopharma Supplies Industry
TipRanks·11/14 02:06
Repligen Director Cashes In on Massive Stock Sale!
Reuters·11/13 21:30
Repligen Director Anthony Hunt Reports Disposal of Common Shares
Same Industry
Name/Symbol
Change%
Price